Pharmacology
A section of Pharmaceuticals (ISSN 1424-8247).
Section Information
This section essentially covers all aspects of pharmacology, including pharmacodynamics, pharmacokinetics and toxicology. Research papers should provide rigorous quantitative analyses and/or new insights on intermolecular reactions of drugs with chemical constituents of cells, tissues, organs or organ systems.
It publishes high quality original research and authoritative reviews, commentary and letters to the editor.
Keywords
- Behavioral pharmacology
- Cancer pharmacology
- Cardiovascular pharmacology
- Chronopharmacology
- Clinical pharmacology
- Immunopharmacology
- Molecular and biochemical pharmacology
- Neuropharmacology
- Pharmacoepidemiology
- Pharmacogenetics/pharmacogenomics
- Pharmacokinetics
- Systems pharmacology
- Toxicology
- Translational pharmacology/medicine
- Safety pharmacology
Editorial Board
Special Issues
Following special issues within this section are currently open for submissions:
- Novel Target for the Treatment of Itch (Pruritus) and Pruritus-Related Pain of Different Origin (Deadline: 31 May 2022)
- Pharmacologic Therapy for Traumatic Brain Injury (Deadline: 31 May 2022)
- Statins Use and Cancer (Deadline: 30 June 2022)
- Drug-induced Ototoxicity: Mechanisms and Otoprotective Strategies (Deadline: 30 June 2022)
- Advances in Non-small Cell Lung Cancer Treatment - Current and Future (Deadline: 30 June 2022)
- Therapeutic Strategies and Targets to Improve the Efficacy of PD-1/PD-L1 Blockade (Deadline: 30 June 2022)
- Phosphodiesterases as Drug Targets: Development and Challenges (Deadline: 29 July 2022)
- Psychoactive Substances: Pharmacology and Toxicology (Deadline: 29 July 2022)
- Drugs for Diabetes: From Pharmacology to Clinical Application (Deadline: 29 July 2022)
- Neuroblastoma Pathogenesis and Therapy (Deadline: 31 July 2022)
- NMDA Receptor-Based Therapeutics (Deadline: 15 August 2022)
- Pharmacokinetics (PK)/Pharmacodynamics (PD) Study in Drug Discovery and Development (Deadline: 15 August 2022)
- Potential Carcinogenicity of Drugs (Deadline: 23 August 2022)
- Rheumatic Diseases: Pathophysiology, Targeted Therapy, Focus on Vascular and Pulmonary Manifestations 2022 (Deadline: 31 August 2022)
- Targeting the Hippo Pathway in Medicine (Deadline: 31 August 2022)
- Optimized or Precise Pharmacological Treatment of Bipolar Disorder (Deadline: 31 August 2022)
- Therapeutic Agents for Neurological Disorders 2022 (Deadline: 31 August 2022)
- Purinergic Signaling: A New Pharmacological Target (Deadline: 31 August 2022)
- Potential Applications of NRF2 Modulators in Therapy (Deadline: 31 August 2022)
- Adipose Tissue as a Therapy and Therapeutic Target for Human Diseases (Deadline: 31 August 2022)
- Emerging Therapies for the Treatment of Cystic Fibrosis (Deadline: 1 September 2022)
- Integrin Function and Signalling as Pharmacological Targets (Deadline: 15 September 2022)
- Recent Advances in TGF-β Inhibitors for the Therapeutic Management of Cancer and Fibrosis (Deadline: 15 September 2022)
- Tryptophan Metabolism as the Therapeutic and Biomarker Target (Deadline: 30 September 2022)
- Targeting Autophagy as a Strategy for Developing New Drugs (Deadline: 30 September 2022)
- Channel Modulation in Neurodegeneration and Neuroprotection (Deadline: 30 September 2022)
- Advances in Behavioral Psychopharmacology (Deadline: 30 September 2022)
- Effects of Drugs on Ion Channels (Deadline: 30 September 2022)
- Therapeutic Target Developments in Pancreatic Cancer (Deadline: 30 September 2022)
- Potential Therapeutic Target for Atherosclerosis (Deadline: 30 September 2022)
- Common Mutations in Gynecologic Cancers (Deadline: 1 October 2022)
- Influence of Chemicals on the Cytoskeleton: Modulation of Stem Cell Dynamics (Deadline: 20 October 2022)
- Pharmacological Advances for Treatment in Hypertension (Deadline: 20 October 2022)
- New Advances in Antiarrhythmic Drugs (Deadline: 21 October 2022)
- Drug Treatments for Inflammatory Bowel Diseases (Deadline: 28 October 2022)
- Recent Advances and Perspectives in the Treatment of Dementia (Deadline: 30 October 2022)
- Evaluation of the Antitumor Mechanism of Armed Antibodies (Deadline: 31 October 2022)
- Astrocytes: Emerging Therapeutic Targets in Neurological Disorders (Deadline: 31 October 2022)
- Effects of Drugs on Low-Density Lipoprotein (LDL) and Lipoprotein (A) Level (Deadline: 15 November 2022)
- Histamine Receptors as Drug Targets (Deadline: 20 November 2022)
- Drug-Induced and Herbal Hepatotoxicity and Methods of Its Prevention (Deadline: 30 November 2022)
- Mitochondria Targeted Pharmaceuticals in Aging Associated Diseases (Deadline: 30 November 2022)
- Pharmacotherapy for Colorectal Cancer (Deadline: 30 November 2022)
- Cytochrome P450 Enzymes in Drug Metabolism (Deadline: 20 December 2022)
- Pharmacotherapy and Tumor Cell Death (Deadline: 22 December 2022)
- Recent Advances in the Pharmacotherapy of Peripheral Nervous System Tumors (Deadline: 31 December 2022)
- Multidrug Resistance in Cancer: Pharmacological Strategies (Deadline: 31 December 2022)
- Recent Advances in Pharmacology of Pulmonary Hypertension (Deadline: 31 December 2022)
- Hydrogen Sulfide Based Therapeutics (Deadline: 28 February 2023)